[1]
J. Gubaljevic, “Serum levels of oxidative stress marker malondialdehyde in breast cancer patients in relation to pathohistological factors, estrogen receptors, menopausal status, and age”, JHSCI, vol. 8, no. 3, pp. 154-161, Dec. 2018.